Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 9 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Pliant Therapeutics Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a 211.28% increase from the last price of 12.85.
High | 250.2% | 45.00 |
Med | 211.3% | 40.00 |
Low | 149.0% | 32.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | -8.21% |
Average growth rate | -13.68% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -45.89% |
More ▼